4/A: TransMedics Group Executive Corrects Ownership Reporting in Amended SEC Filing

Tamer Khayal, Chief Commercial Officer of TransMedics Group, files an amended Form 4 to correct a clerical error regarding the direct and indirect ownership of common stock.

Summary

• Tamer Khayal, Chief Commercial Officer of TransMedics Group, Inc. (TMDX), filed an amended Form 4 with the SEC on May 14, 2024.
• This amendment corrects a clerical error in the original Form 4 filed on May 8, 2024.
• The error incorrectly reported that 11,051 shares of TransMedics Group's common stock beneficially owned by Khayal were owned by the Tamer Ibrahim Ahmed Khayal Trust.
• The amended form clarifies that these 11,051 shares are directly owned by Khayal, not by the trust.
• The filing also indicates that Khayal directly owns 20,843 shares of common stock and indirectly owns shares through the Tamer Ibrahim Ahmed Khayal Trust.

Sentiment

Score: 7

Explanation: The document is a routine correction of a clerical error in an SEC filing. It doesn't indicate any significant positive or negative developments for the company, but transparency and compliance are generally viewed favorably.

Industry Context

This is a routine filing related to insider ownership and is specific to TransMedics Group and its executive, Tamer Khayal. It doesn't directly reflect broader industry trends but ensures compliance with SEC regulations regarding transparency of insider holdings.

Stakeholder Impact

• The correction of the filing ensures accurate information is available to shareholders regarding insider ownership.
• This promotes transparency and trust in the company's reporting practices.

Key Dates